> top > docs > PMC:7205724 > spans > 101-282 > annotations

PMC:7205724 / 101-282 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 151-158 Species denotes patient Tax:9606

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 31-46 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T2 52-67 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T3 120-135 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T1 31-46 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes immunoglobulins http://purl.bioontology.org/ontology/MEDDRA/10021496

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 52-67 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T2 120-135 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T3 14-67 Sentence denotes Anti-antibodies, immunoglobulins, and corticosteroids
T4 69-79 Sentence denotes Highlights
T5 80-168 Sentence denotes • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
3 151-158 Species denotes patient Tax:9606

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T15 6-12 NNS denotes agents
T16 12-13 -COLON- denotes :
T17 14-29 NNS denotes Anti-antibodies
T18 29-30 -COMMA- denotes ,
T19 31-46 NNS denotes immunoglobulins
T20 46-47 -COMMA- denotes ,
T21 48-51 CC denotes and
T22 52-67 NNS denotes corticosteroids
T23 69-79 NNS denotes Highlights
T24 80-81 IN denotes •
T25 83-87 NNP denotes IVIG
T26 87-88 -COMMA- denotes ,
T27 89-97 VBN denotes combined
T28 98-102 IN denotes with
T29 103-116 NN denotes moderate-dose
T30 117-119 IN denotes of
T31 120-135 NNS denotes corticosteroids
T32 135-136 -COMMA- denotes ,
T33 137-142 MD denotes might
T34 143-150 VB denotes improve
T35 151-158 NN denotes patient
T36 159-167 NNS denotes outcomes
T37 169-170 PDT denotes •
T38 172-175 DT denotes The
T39 176-179 NN denotes use
R15 T17 T18 arg1Of Anti-antibodies,","
R16 T19 T18 arg2Of immunoglobulins,","
R17 T21 T20 arg1Of and,","
R18 T18 T21 arg1Of ",",and
R19 T22 T21 arg2Of corticosteroids,and
R20 T25 T24 arg1Of IVIG,•
R21 T25 T26 arg1Of IVIG,","
R22 T25 T27 arg2Of IVIG,combined
R23 T27 T28 arg1Of combined,with
R24 T29 T28 arg2Of moderate-dose,with
R25 T29 T30 arg1Of moderate-dose,of
R26 T31 T30 arg2Of corticosteroids,of
R27 T34 T32 arg1Of improve,","
R28 T25 T33 arg1Of IVIG,might
R29 T34 T33 arg2Of improve,might
R30 T25 T34 arg1Of IVIG,improve
R31 T36 T34 arg2Of outcomes,improve
R32 T36 T35 arg1Of outcomes,patient
R33 T39 T37 arg1Of use,•
R34 T39 T38 arg1Of use,The

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 31-46 Body_part denotes immunoglobulins http://purl.org/sig/ont/fma/fma62871

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T3 14-67 Sentence denotes Anti-antibodies, immunoglobulins, and corticosteroids
T4 69-79 Sentence denotes Highlights
T5 80-168 Sentence denotes • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.